Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Eschscholzia Tablets in Adults With Insomnia Disorder Symptoms: A Monocentric, Randomized, Double-blind, Placebo-controlled, Parallel Group, Prospective Study

NCT06795776 is registered in ClinicalTrials.gov with A. Vogel AG as lead sponsor.

NCT NCT06795776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Eschscholzia Tablets in Adults With Insomnia Disorder Symptoms: A Monocentric, Randomized, Double-blind, Placebo-controlled, Parallel Group, Prospective Study
Lead sponsor
A. Vogel AG
Phase
Phase 3
Overall status
Completed
Start date
April 7, 2025
Completion date
November 4, 2025
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep